Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke

This publication has 15 references indexed in Scilit:

• Termination of trial of streptokinase in severe acute ischaemic stroke
  The Lancet, 1995
• Telephone Interview for Stroke Outcome Assessment
  Cerebrovascular Diseases, 1994
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• Thrombolysis in acute ischemic stroke: does it work?
  Stroke, 1992
• Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
  Annals of Neurology, 1992
• Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.
  Stroke, 1992
• Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits.
  Stroke, 1991
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• Platelets and Thrombolytic Therapy
  New England Journal of Medicine, 1990